MetLife Investment Management’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,230
| Closed | -$99.5K | – | 2871 |
|
|
2025
Q3 | $99.5K | Sell |
16,230
-1,304
| -7% | -$8.25K | ﹤0.01% | 2656 |
|
|
2025
Q2 | $114K | Buy |
17,534
+6,758
| +63% | +$36.4K | ﹤0.01% | 2471 |
|
|
2025
Q1 | $57.2K | Sell |
10,776
-5,110
| -32% | -$34.9K | ﹤0.01% | 2674 |
|
|
2024
Q4 | $133K | Buy |
15,886
+3,028
| +24% | +$23.4K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $101K | Sell |
12,858
-5,131
| -29% | -$46.2K | ﹤0.01% | 2622 |
|
|
2024
Q2 | $185K | Buy |
17,989
+3,705
| +26% | +$40.1K | ﹤0.01% | 2301 |
|
|
2024
Q1 | $179K | Sell |
14,284
-2,871
| -17% | -$37.1K | ﹤0.01% | 2256 |
|
|
2023
Q4 | $263K | Hold |
17,155
| – | – | ﹤0.01% | 2076 |
|
|
2023
Q3 | $252K | Hold |
17,155
| – | – | ﹤0.01% | 2072 |
|
|
2023
Q2 | $304K | Hold |
17,155
| – | – | ﹤0.01% | 2007 |
|
|
2023
Q1 | $305K | Hold |
17,155
| – | – | ﹤0.01% | 1947 |
|
|
2022
Q4 | $336K | Hold |
17,155
| – | – | ﹤0.01% | 1894 |
|
|
2022
Q3 | $327K | Buy |
17,155
+1,294
| +8% | +$26.2K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $284K | Sell |
15,861
-2,079
| -12% | -$48.8K | ﹤0.01% | 2052 |
|
|
2022
Q1 | $518K | Buy |
17,940
+6,984
| +64% | +$192K | ﹤0.01% | 1750 |
|
|
2021
Q4 | $303K | Hold |
10,956
| – | – | ﹤0.01% | 1807 |
|
|
2021
Q3 | $297K | Sell |
10,956
-2,939
| -21% | -$78.6K | ﹤0.01% | 1828 |
|
|
2021
Q2 | $391K | Hold |
13,895
| – | – | ﹤0.01% | 1727 |
|
|
2021
Q1 | $306K | Sell |
13,895
-1,527
| -10% | -$31.3K | ﹤0.01% | 1802 |
|
|
2020
Q4 | $288K | Hold |
15,422
| – | – | ﹤0.01% | 1787 |
|
|
2020
Q3 | $239K | Hold |
15,422
| – | – | ﹤0.01% | 1757 |
|
|
2020
Q2 | $235K | Hold |
15,422
| – | – | ﹤0.01% | 1803 |
|
|
2020
Q1 | $197K | Hold |
15,422
| – | – | ﹤0.01% | 1705 |
|
|
2019
Q4 | $371K | Sell |
15,422
-4,151
| -21% | -$94.7K | ﹤0.01% | 1621 |
|
|
2019
Q3 | $413K | Hold |
19,573
| – | – | ﹤0.01% | 1527 |
|
|
2019
Q2 | $432K | Hold |
19,573
| – | – | ﹤0.01% | 1572 |
|
|
2019
Q1 | $463K | Hold |
19,573
| – | – | 0.01% | 1498 |
|
|
2018
Q4 | $435K | Hold |
19,573
| – | – | 0.01% | 1452 |
|
|
2018
Q3 | $510K | Hold |
19,573
| – | – | 0.01% | 1530 |
|
|
2018
Q2 | $527K | Hold |
19,573
| – | – | 0.01% | 1382 |
|
|
2018
Q1 | $507K | Hold |
19,573
| – | – | 0.01% | 1355 |
|
|
2017
Q4 | $538K | Buy |
+19,573
| New | +$519K | 0.01% | 1358 |
|
Other funds holding TBI
RA
ACM
MetLife Investment Management's TBI Position: Q4 2025 in Review
MetLife Investment Management sold out of Trueblue (TBI) in Q4 2025, closing a stake of 16,230 shares — an estimated $99.5K sold.
MetLife Investment Management first reported a position in TBI in Q4 2017 and held it in 32 quarters. The position peaked at $538K in Q4 2017. 110 funds tracked by Wall St. Rank hold TBI as of Q4 2025.
- MetLife Investment Management reported no remaining Trueblue position as of Q4 2025 after selling out during the quarter.
- MetLife Investment Management sold 16,230 Trueblue shares in Q4 2025, an estimated $99.5K.
- MetLife Investment Management first reported a position in Trueblue in Q4 2017 and held it in 32 quarters.
- MetLife Investment Management's Trueblue position peaked at $538K in Q4 2017.
- 110 funds tracked by Wall St. Rank held Trueblue as of Q4 2025.
Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.